Patents/Assignees

Hengda Biomedical Technology Co., Ltd.

1 patent in portfolio

US12226473utility2025
SARS-COV-2 Antigen Polypeptide, Recombinant Adeno-associated Virus Expressing the Polypeptide, and Vaccine Containing the Virus
0 cites